Back to results
US 2010/0076065 A1Published application
Vitamin d receptor modulators
AssigneeEli Lilly and Company
InventorsJianliang Lu, Tainwei Ma, Sunil Nagpal, Quanrong Shen, Alan M. Warshawsky, Ying Kwong Yee, Michael John Rupp
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
Claims6
1-29. (canceled)
A method of treating a mammal in need thereof for disease states selected from:
- acne, actinic keratosis, scleroderma, and seborrheic dermatitis wherein the method comprises administering a pharmaceutically effective amount of a compound of the following structure:
Dependencies are inferred from the claim text.